Cost-consequence analysis of Pharmaceutical Care program for systemic arterial hypertension in the public health system in Brazil
ABSTRACT In Brazil, 80% of hypertensive patients have no blood pressure controlled, this fact has caused severe financial consequences for the public health system (PHS) and the Pharmaceutical Care (PC) has emerged as an effective alternative. The aim of this study was to analyze the costs and outco...
Saved in:
Main Authors: | Maurílio de Souza Cazarim (Author), Altacílio Aparecido Nunes (Author), Leonardo Régis Leira Pereira (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system
by: Maurílio de Souza Cazarim, et al.
Published: (2017) -
Effect of Medication Therapy Management by Pharmaceutical Care on Blood Pressure and Cardiovascular Risk in Hypertension: A Systematic Review, Meta-Analysis, and Meta-Regression
by: Maurilio de Souza Cazarim, et al.
Published: (2023) -
Systematic review protocol: following PRISMA guide from Cochrane to generate evidence as treatment effect of pharmaceutical care for hypertension in primary care
by: Maurílio de Souza Cazarim, et al.
Published: (2021) -
Cost-effectiveness analysis is a mandatory strategy for health systems: evidence from a study involving therapies for hepatitis C
by: João Paulo Vilela Rodrigues, et al. -
How much to invest in glycemic control of a patient with diabetes mellitus type 2? A constant dilemma for the Brazilian Public Health System (SUS)
by: Ana Carolina de Oliveira Gonçalves, et al.